These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 10616974

  • 1. Pharmacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppression.
    Letsou GV, Safi HJ, Reardon MJ, Ergenoglu M, Li Z, Klonaris CN, Baldwin JC, Gilbert BE, Waldrep JC.
    Ann Thorac Surg; 1999 Dec; 68(6):2044-8. PubMed ID: 10616974
    [Abstract] [Full Text] [Related]

  • 2. Biokinetics of Aerosolized Liposomal Ciclosporin A in Human Lung Cells In Vitro Using an Air-Liquid Cell Interface Exposure System.
    Schmid O, Jud C, Umehara Y, Mueller D, Bucholski A, Gruber F, Denk O, Egle R, Petri-Fink A, Rothen-Rutishauser B.
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):411-424. PubMed ID: 28683218
    [Abstract] [Full Text] [Related]

  • 3. Characterization and administration of cyclosporine liposomes as a small-particle aerosol.
    Gilbert BE, Wilson SZ, Garcon NM, Wyde PR, Knight V.
    Transplantation; 1993 Oct; 56(4):974-7. PubMed ID: 8212222
    [Abstract] [Full Text] [Related]

  • 4. Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation.
    Behr J, Zimmermann G, Baumgartner R, Leuchte H, Neurohr C, Brand P, Herpich C, Sommerer K, Seitz J, Menges G, Tillmanns S, Keller M, Munich Lung Transplant Group.
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):121-30. PubMed ID: 19422312
    [Abstract] [Full Text] [Related]

  • 5. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study.
    Blot F, Tavakoli R, Sellam S, Epardeau B, Faurisson F, Bernard N, Becquemin MH, Frachon I, Stern M, Pocidalo JJ.
    J Heart Lung Transplant; 1995 Jun; 14(6 Pt 1):1162-72. PubMed ID: 8719464
    [Abstract] [Full Text] [Related]

  • 6. Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation.
    Keenan RJ, Duncan AJ, Yousem SA, Zenati M, Schaper M, Dowling RD, Alarie Y, Burckart GJ, Griffith BP.
    Transplantation; 1992 Jan; 53(1):20-5. PubMed ID: 1733067
    [Abstract] [Full Text] [Related]

  • 7. Lung deposition and pharmacokinetics of nebulized cyclosporine in lung transplant patients.
    Corcoran TE, Niven R, Verret W, Dilly S, Johnson BA.
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):178-84. PubMed ID: 23668548
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a new pulmonary cyclosporine a powder formulation for prevention of transplant rejection in rats.
    Zijlstra GS, Wolting J, Prop J, Petersen AH, Hinrichs WL, Uges DR, Kerstjens HA, van der Bij W, Frijlink HW.
    J Heart Lung Transplant; 2009 May; 28(5):486-92. PubMed ID: 19416778
    [Abstract] [Full Text] [Related]

  • 9. Inhaled delivery of aerosolized cyclosporine.
    Corcoran TE.
    Adv Drug Deliv Rev; 2006 Oct 31; 58(9-10):1119-27. PubMed ID: 16997418
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles.
    Lee MK, Choi L, Kim MH, Kim CK.
    Int J Pharm; 1999 Nov 30; 191(2):87-93. PubMed ID: 10564835
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients.
    Burkart GJ, Smaldone GC, Eldon MA, Venkataramanan R, Dauber J, Zeevi A, McCurry K, McKaveney TP, Corcoran TE, Griffith BP, Iacono AT.
    Pharm Res; 2003 Feb 30; 20(2):252-6. PubMed ID: 12636164
    [Abstract] [Full Text] [Related]

  • 13. Dose-related reversal of acute lung rejection by aerosolized cyclosporine.
    Iacono AT, Smaldone GC, Keenan RJ, Diot P, Dauber JH, Zeevi A, Burckart GJ, Griffith BP.
    Am J Respir Crit Care Med; 1997 May 30; 155(5):1690-8. PubMed ID: 9154878
    [Abstract] [Full Text] [Related]

  • 14. In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.
    Matilainen L, Järvinen K, Toropainen T, Näsi E, Auriola S, Järvinen T, Jarho P.
    Int J Pharm; 2006 Aug 02; 318(1-2):41-8. PubMed ID: 16624508
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunosuppression with aerosolized cyclosporine for prevention of lung rejection in a rat model.
    Zenati M, Duncan AJ, Burckart GJ, Schaper M, Yousem SA, Griffith BP, Casarotto D.
    Eur J Cardiothorac Surg; 1991 Aug 02; 5(5):266-71; discussion 272. PubMed ID: 1859667
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol.
    Gilbert BE, Knight C, Alvarez FG, Waldrep C, Rodarte JR, Knight V, Eschenbacher WL.
    Am J Respir Crit Care Med; 1997 Dec 02; 156(6):1789-93. PubMed ID: 9412556
    [Abstract] [Full Text] [Related]

  • 19. Toward managing chronic rejection after lung transplant: the fate and effects of inhaled cyclosporine in a complex environment.
    Niven RW.
    Adv Drug Deliv Rev; 2011 Dec 02; 63(1-2):88-109. PubMed ID: 20950661
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.